Asthma Degenerative Disease
Asthma is a common chronic inflammatory disease of the airways characterized by symptoms including wheezing, coughing, chest tightness, and shortness of breath, reversible airflow obstruction, and bronchospasm. Asthma is clinically classified according to the frequency of symptoms, forced expiratory volume in 1 second (FEV1), and peak expiratory flow rate. Asthma may also be classified as atopic (extrinsic) or non-atopic (intrinsic). It can be exercised induced or occupational. Asthma affects an estimated 300 million people worldwide and caused 250,000 deaths in 2009. Traditional management usually focuses on reduction to allergen exposure and medical therapy that consists of beta-2-agonists, anti-cholinergics, or inhaled corticosteroids.
Asthma and Mississsippi Stem Cell Therapy Center
Asthma research has been ongoing around the world and at Mississsippi Stem Cell Therapy Center that exploits the anti-inflammatory and immuno-modulatory properties of adult stem cells to control the reactive airways associated with asthma. Mississsippi Stem Cell Therapy Center is investigating the effects of SVF (rich in mesenchymal stem cells and growth factors) on chronic asthma. We use a protocol that includes a combination of intravenous and nebulized SVF delivery. Subjective reports, changes in steroid use and pulmonary function tests help measure outcomes in a meaningful way.
Asthma Call to Action
We care about our Asthma patients at Mississsippi Stem Cell Therapy Center and the Cell Surgical Network and take pride in the time we provide to our patients to deploy the best protocols to help our patients achieve their goals. By filling out GCSCRMC Confidential Candidate Application, we will answer the questions and concerns you may have about Mississsippi Stem Cell Therapy Center and Cell Surgical Network protocols for Asthma. Our Cell Surgical Network has Treatment Centers in several states, checkout our Physician Network to find the closest Treatment Center Our Physician Network Map